The 3VHE protein is considered as a potential target for the treatment of prostate cancer. In order to find new 3VHE inhibitors, pharmacophore models based on the molecular structure of rhodanine derivatives and a three-dimensional quantitative structure-activity relationship model (3D-QSAR) have been developed and validated by different methods. The 3D-QSAR model was evaluated for its predictive performance on a diverse test set containing 18 prostate cancer inhibitors. It presents very interesting internal and external statistical validation parameters (SD = 0.081; R2 = 0.903; Q2 = 0.869; ; F = 247.2). This result suggests that the 3D-QSAR combinatorial model can be used to search for new 3VHE inhibitors and predict their potential activity. Based on the combinatorial pharmacophore model, a virtual screening of the Enamine database was performed. Compounds selected after virtual screening were subjected to molecular docking protocols (HTVS, SP, XP and IFD). Twenty new active compounds have been identified and their absorption, distribution, metabolism and excretion (ADME) property calculated using Schr?dinger’s Qikprop module. These results suggest that these new compounds could constitute new chemical starting points for further structural optimization of 3VHE inhibitors.
References
[1]
Parkin, D., Bray, F. and Devesa, S. (2001) Cancer Burden in the Year 2000. The Global Picture. European Journal of Cancer, 37, 466. https://doi.org/10.1016/S0959-8049(01)00267-2
[2]
Jeong, T.-S., Kim, J.-R., Kim, K.S., Cho, K.-H., Bae, K.-H. and Lee, W.S. (2004) Inhibitory Effects of Multi-Substituted Benzylidenethiazolidine-2, 4-Diones on LDL Oxidation. Bioorganic & Medicinal Chemistry, 12, 4017-4023. https://doi.org/10.1016/j.bmc.2004.06.001
[3]
Koppireddi, S., Komsani, J.R., Avula, S., Pombala, S., Vasamsetti, S., Kotamraju, S. and Yadla, R. (2013) Novel 2-(2,4-dioxo-1,3-thiazolidin-5-yl) Acetamides as Antioxidant and/or Anti-Inflammatory Compounds. European Journal of Medicinal chemistry, 66, 305-313. https://doi.org/10.1016/j.ejmech.2013.06.005
[4]
Barros, C.D., Amato, A.A., de Oliveira, T.B., Iannini, K.B.R., da Silva, A.L., da Silva, T.G., Leite, E.S., Hernandes, M.Z., de Lima, M.d.C.A. and Galdino, S.L. (2010) Synthesis and Anti-Inflammatory Activity of New Arylidene-Thiazolidine-2,4-Diones as PPARγ Ligands. Bioorganic & Medicinal Chemistry, 18, 3805-3811. https://doi.org/10.1016/j.bmc.2010.04.045
[5]
Heerding, D.A., Christmann, L.T., Clark, T.J., Holmes, D.J., Rittenhouse, S.F., Takata, D.T. and Venslavsky, J.W. (2003) New Benzylidenethiazolidinediones as Antibacterial Agents. Bioorganic & Medicinal Chemistry Letters, 13, 3771-3773. https://doi.org/10.1016/j.bmcl.2003.07.010
[6]
Trotsko, N., Kosikowska, U., Paneth, A., Wujec, M. and Malm, A. (2018) Synthesis and Antibacterial Activity of New (2,4-Dioxothiazolidin-5-yl/ylidene) Acetic Acid Derivatives with Thiazolidine-2,4-Dione, Rhodanine and 2-Thiohydantoin Moieties. Saudi Pharmaceutical Journal, 26, 568-577. https://doi.org/10.1016/j.jsps.2018.01.016
[7]
Marc, G., Ionuț, I., Pirnau, A., Vlase, L., Vodnar, D.C., Duma, M., Tiperciuc, B. and Oniga, O. (2017) Microwave Assisted Synthesis of 3,5-Disubstituted Thiazolidine-2,4-Diones with Antifungal Activity. Design, Synthesis, Virtual and in Vitro Antifungal Screening. Farmacia, 65, 414-422.
[8]
Tuncbilek, M. and Altanlar, N. (2006) Synthesis of New 3-(Substituted Phenacyl)-5-[3’-(4H-4-oxo-1-benzopyran-2-yl)-benzylidene]-2,4-Thiazolidinediones and Their Antimicrobial Activity. Archiv der Pharmazie, 339, 213-216. https://doi.org/10.1002/ardp.200500180
[9]
Liu, X.-F., Zheng, C.-J., Sun, L.-P., Liu, X.-K. and Piao, H.-R. (2011) Synthesis of New Chalcone Derivatives Bearing 2, 4-Thiazolidinedione and Benzoic Acid Moieties as Potential Anti-Bacterial Agents. European Journal of Medicinal Chemistry, 46, 3469-3473. https://doi.org/10.1016/j.ejmech.2011.05.012
[10]
Ibrahim, M.A., Abdel-Hamed, M.A.-M. and El-Gohary, N.M. (2011) A New Approach for the Synthesis of Bioactive Heteroaryl Thiazolidine-2, 4-Diones. Journal of the Brazilian Chemical Society, 22, 1130-1139. https://doi.org/10.1590/S0103-50532011000600019
[11]
Mousavi, S.M., Zarei, M., Hashemi, S.A., Babapoor, A. and Amani, A.M. (2019) A Conceptual Review of Rhodanine. Artificial Cells, Nanomedicine, and Biotechnology, 47, 1132-1148. https://doi.org/10.1080/21691401.2019.1573824
[12]
Almeida, V.L.d., Lopes, J.C.D., Oliveira, S.R., Donnici, C.L. and Montanari, C.A. (2010) Estudos de relações estrutura-atividade quantitativas (QSAR) de bis-benzamidinas com atividade antifúngica. Química Nova, 33, 1482-1489. https://doi.org/10.1590/S0100-40422010000700011
Cantello, B.C.C., Cawthorne, M.A., Haigh, D., Hindley, R.M., Smith, S.A. and Thurlby, P.L. (1994) The Synthesis of BRL 49653—A Novel and Potent Antihyperglycaemic Agent. Bioorganic & Medicinal Chemistry Letters, 4, 1181-1184. https://doi.org/10.1016/S0960-894X(01)80325-5
[15]
Coulibaly, W.K., Paquin, L., Bénié, A., Bekro, Y.-A., Durieux, E., Meijer, L., Le Guével, R., Corlu, A. and Bazureau, J.-P. (2012) Synthesis of New N,N’-Bis (5-Arylidene-4-Oxo-4,5-Dihydrothiazolin-2-Yl) Piperazine Derivatives under Microwave Irradiation and Preliminary Biological Evaluation. Scientia Pharmaceutica, 80, 825-836. https://doi.org/10.3797/scipharm.1206-04
[16]
Schrödinger Release 2017-4: LigPrep (2017). Schrödinger, LLC, New York.
[17]
Shivakumar, D., Williams, J., Wu, Y., Damm, W., Shelley, J. and Sherman, W. (2010) Prediction of Absolute Solvation Free Energies Using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field. Journal of Chemical Theory and Computation, 6, 1509-1519. https://doi.org/10.1021/ct900587b
[18]
Dixon, S.L., Smondyrev, A.M., Knoll, E.H., Rao, S.N., Shaw, D.E. and Friesner, R.A. (2006) PHASE: A New Engine for Pharmacophore Perception, 3D QSAR Model Development, and 3D Database Screening: 1. Methodology and Preliminary Results. Journal of Computer-Aided Molecular Design, 20, 647-671. https://doi.org/10.1007/s10822-006-9087-6
[19]
Dixon, S.L., Smondyrev, A.M. and Rao, S.N. (2006) PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching. Chemical Biology & Drug Design, 67, 370-372. https://doi.org/10.1111/j.1747-0285.2006.00384.x
[20]
Huang, N., Shoichet, B.K. and Irwin, J.J. (2006) Benchmarking Sets for Molecular Docking. Journal of Medicinal Chemistry, 49, 6789-6801. https://doi.org/10.1021/jm0608356
[21]
Mysinger, M.M., Carchia, M., Irwin, J.J. and Shoichet, B.K. (2012) Directory of Useful Decoys, Enhanced (DUD-E). Journal of Medicinal Chemistry, 55, 6582-6594. https://doi.org/10.1021/jm300687e
[22]
Schrödinger Release 2017-4: Phase (2017). Schrödinger, LLC, New York.
[23]
Braga, R.C. and Andrade, C.H. (2013) Assessing the Performance of 3D Pharmacophore Models in Virtual Screening. Current Topics in Medicinal Chemistry, 13, 1127-1138. https://doi.org/10.2174/1568026611313090010
[24]
Yang, J.M. and Shen, T.W. (2005) A Pharmacophore Based Evolutionary Approach for Screening Selective. Proteins: Structure, Function, and Bioinformatics, 59, 205-220. https://doi.org/10.1002/prot.20387
[25]
Teli, M.K. and Rajanikant, G.K. (2012) Pharmacophore Generation and Atom-Based 3D-QSAR of Novel Quinoline-3-Carbonitrile Derivatives as Tpl2 Kinase Inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 27, 558-570. https://doi.org/10.3109/14756366.2011.603128
[26]
Prakash Tanwar, O., Karthikeyan, C., Hari Narayana Moorthy, N.S. and Trivedi, P. (2010) 3D QSAR of Aminophenyl Benzamide Derivatives as Histone Deacetylase Inhibitors. Medicinal Chemistry, 6, 277-285. https://doi.org/10.2174/157340610793358846
[27]
Wang, H., Aslanian, R. and Madison, V.S. (2008) Induced-Fit Docking of Mometasone Furoate and Further Evidence for Glucocorticoid Receptor 17α Pocket Flexibility. Journal of Molecular Graphics and Modelling, 27, 512-521. https://doi.org/10.1016/j.jmgm.2008.09.002
[28]
Saubern, S., Guha, R. and Baell, J.B. (2011) KNIME Workflow to Assess PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Cheminformatics Libraries. Molecular Informatics, 30, 847-850. https://doi.org/10.1002/minf.201100076
[29]
Schrödinger Release 2017-4: QikProp (2017). Schrödinger, LLC, New York.
[30]
Samal, S.K., Routray, S., Veeramachaneni, G.K., Dash, R. and Botlagunta, M. (2015) Ketorolac Salt Is a Newly Discovered DDX3 Inhibitor to Treat Oral Cancer. Scientific Reports, 5, Article No. 9982. https://doi.org/10.1038/srep09982
[31]
Truchon, J.-F. and Bayly, C.I. (2007) Evaluating Virtual Screening Methods. Journal of Chemical Information and Modeling, 47, 488-508. https://doi.org/10.1021/ci600426e
[32]
Kumar, A., Roy, S., Tripathi, S. and Sharma, A. (2016) Molecular Docking Based Virtual Screening of Natural Compounds as Potential BACE1 Inhibitors. Journal of Biomolecular Structure and Dynamics, 34, 239-249. https://doi.org/10.1080/07391102.2015.1022603
[33]
Imberty, A., Hardman, K.D., Carver, J.P. and Perez, S. (1991) Molecular Modelling of Protein-Carbohydrate Interactions. Docking of Monosaccharides in the Binding Site of Concanavalin A. Glycobiology, 1, 631-642. https://doi.org/10.1093/glycob/1.6.631
[34]
Sindhu, T. and Srinivasan, P. (2014) Pharmacophore Modeling, 3D-QSAR and Molecular Docking Studies of Benzimidazole Derivatives as Potential FXR Agonists. Journal of Receptor and Signal Transduction Research, 34, 241-253. https://doi.org/10.3109/10799893.2014.885048
[35]
Veerasamy, R., Rajak, H., Jain, A., Sivadasan, S., Varghese, C.P. and Agrawal, R.K. (2011) Validation of QSAR Models-Strategies and Importance. International Journal of Drug Design and Discovery, 2, 511-519.
[36]
Berman, E. and Machin, S. (2000) Skill-Biased Technology Transfer around the World. Oxford Review of Economic Policy, 16, 12-22. https://doi.org/10.1093/oxrep/16.3.12
[37]
Rask-Andersen, M., Masuram, S. and Schiöth, H.B. (2014) The Druggable Genome. Annual Review of Pharmacology and Toxicology, 54, 9-26. https://doi.org/10.1146/annurev-pharmtox-011613-135943
[38]
Lengauer, T., Lemmen, C., Rarey, M. and Zimmermann, M. (2004) Novel Technologies for Virtual Screening. Drug discovery today, 9, 27-34. https://doi.org/10.1016/S1359-6446(04)02939-3
[39]
Schrödinger Release 2017-4: Glide (2017). Schrödinger, LLC, New York.
[40]
Li, H. (2011) A statistical Framework for SNP Calling, Mutation Discovery, Association Mapping and Population Genetical Parameter Estimation from Sequencing Data. Bioinformatics, 27, 2987-2993. https://doi.org/10.1093/bioinformatics/btr509
